Skip to main content
TipRanks
Go Ultimate75% OFF

Metro Inc. (MTRAF) AI Stock Analysis

2 Followers
MTRAF

Metro Inc.

(Other OTC:MTRAF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong Free Cash FlowMetro generates substantial recurring free cash flow, giving it internal funding for store, pharmacy, technology and e-commerce investment. This supports capital returns while reducing reliance on external financing, although recent cash-flow growth has moderated.
Negative Factors
Higher LeverageThe recent increase in debt raises fixed financial obligations and limits flexibility relative to a lower-leverage balance sheet. Higher borrowing also increases sensitivity to financing costs, potentially constraining investment or capital returns if operating performance weakens.

Metro Inc. (MTRAF) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%MTRAF-1.38%SPY+9.80%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$20.28B
Dividend Yield
1.80%
Average Volume (3M)
72.25K
Price to Earnings (P/E)
23.0
Beta (1Y)
-0.15
Revenue Growth
3.18%
EPS Growth
-9.19%
Country
US
Employees
99,000
Sector
Consumer Defensive
Sector Strength
62
Industry
Grocery Stores

Metro Inc. Business Overview & Revenue Model

Company Description

Metro Inc. is a prominent Canadian enterprise active across the food and pharmaceutical industries, functioning as a retailer, franchisor, distributor, and manufacturer. Its operations encompass supermarkets and discount stores, offering a comprehens...

Metro Inc. Earnings Call Summary

Earnings Call Date:Nov 18, 2026(Q4-2026)|% Change Since:-4.49%|Next Earnings Date:Jan 26, 2027
Earnings Call SentimentNeutral

The call presented a mixed outlook. Fiscal 2026 fourth-quarter results were materially pressured by the Laval labor conflict, weaker food same-store sales, lower margins and declines in adjusted EBITDA, net earnings and EPS. However, pharmacy performance remained strong, the distribution center recovered ahead of plan, discount stores were performing well, and management outlined continued investment and a gradual recovery plan for the food business. The positive pharmacy and recovery trends were balanced by the significant current-period financial and operating challenges.

Positive Updates

Quarterly Sales Increased
Fourth-quarter sales reached $5.2 billion, an increase of 1.4% versus the fourth quarter last year, positively impacted by new store openings.

Negative Updates

Food Same-Store Sales Declined
Food same-store sales decreased 1.9% in the quarter. Comparable customer traffic was down, only partially offset by growth in the average basket, while the labor conflict affected freshness, assortment and the company's ability to compete.

Company Guidance

For fiscal '27, Metro expects CapEx to reach approximately $500 million, square footage growth to be around 1%, 9 remaining Metro-to-Food Basics conversions and 7 new discount stores, bringing the total to an expected 16 additional stores to its discount network by year-end, plus 3 new pharmacy openings and 31 renovation projects, including 13 pharmacies equipped with the new pharmacy concept. The e-commerce fulfillment-model transition should be completed by the end of Q1, food same-store sales are still negative but have started to improve, sales will improve gradually and margin will improve gradually, and Bill 67 is expected to result in a gradual ramp-up. Metro remains committed to its EPS framework of 8% to 10% growth annually, expects to renew its NCIB, and expects share buyback to be similar, if not a touch more.

Metro Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

MTRAF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:LTSE:L78OutperformCAD 81.56B29.6725.25%0.84%3.07%32.80%
TSE:DOLTSE:DOL74OutperformCAD 58.01B43.1197.52%0.22%17.86%10.53%
TSE:NWCTSE:NWC68NeutralCAD 2.78B19.6517.50%2.83%0.88%2.80%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
TSE:WNTSE:WN60NeutralCAD 41.65B42.8520.42%1.11%3.74%-0.07%
TSE:EMP.ATSE:EMP.A55NeutralCAD 11.44B52.544.27%1.80%2.45%-67.24%

* Consumer Defensive Sector Average

Performance Comparison

-10%0%10%20%MTRAFTSE:LTSE:DOLTSE:EMP.ATSE:NWCTSE:WNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MTRAF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MTRAFMetro Inc.67.41-2.53-3.62%
TSE:LLoblaw Companies70.928.4813.59%
TSE:DOLDollarama215.9918.819.54%
TSE:EMP.AEmpire Co Cl A Nv51.490.300.58%
TSE:NWCNorth West58.3511.5724.72%
TSE:WNGeorge Weston Limited111.8416.7617.63%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.